Mega Lifesciences Public Company Limited (MEGA)
Thailand Exchange · Thailand · prices in THB · close of 19 Oct 2026
Key indicators
| Last close | THB 32.75 |
|---|---|
| 52-week range | 26.51 – 38.84 |
| Return, 1 month / 3 months | −9.0% / −11.8% |
| Return, 1 year / 3 years | +10.6% / −15.3% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 33.4% |
| Worst drawdown (1 year) | -18.9% |
| Average daily value traded | 31.73M THB |
| Dividend yield | 5.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mega Lifesciences Public Company Limited is a pharmaceutical company based in Thailand. It develops, manufactures and markets branded generic medicines, nutritional supplements and consumer health products. Its customers include hospitals, clinics, pharmacies and distributors, and its products reach patients in Thailand and in emerging markets across Asia, Africa, the Middle East and Latin America. The company also provides contract manufacturing and distribution services for other healthcare businesses.
Mega Lifesciences Public Company Limited trades under the code MEGA on the Thailand Exchange in Thailand, with its price quoted in Thai baht (THB). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mega Lifesciences Public Company Limited (MEGA) trades on the Thailand Exchange in Thailand. It last closed at THB 32.75 on 19 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 577 of 1,348 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.6% and over the last three months it fell 11.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Thailand Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.8% | ||
| From 52-week high | -15.1% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.8% | ||
| 6-month return | -1.4% | ||
| 12-month return, skipping the last month | 21.6% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.9% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 31.73M THB | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | −9.0% |
| 3 months | −11.8% |
| 6 months | −1.4% |
| 1 year | +10.6% |
| 3 years | −15.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 35.40 / 34.78 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.67 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Aug 2026 | THB 0.8500 |
| 9 Mar 2026 | THB 0.8000 |
| 27 Aug 2025 | THB 0.8000 |
| 7 Mar 2025 | THB 0.8000 |
| 23 Aug 2024 | THB 0.3000 |
| 6 Mar 2024 | THB 0.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Thailand Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.